Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Homogeneous Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1257468A reveals novel Cp*-metal catalysts for efficient asymmetric transfer hydrogenation, offering significant cost reduction in pharmaceutical manufacturing and safer processing.
Novel homogeneous catalytic process for Serinol production reduces steps and waste, offering cost reduction in API intermediate manufacturing and reliable supply chain continuity.
Patent CN1599743A discloses novel tropp ligands enabling high-efficiency asymmetric hydrogenation. Ideal for pharmaceutical intermediate manufacturing with reduced costs.
Patent CN107400044B discloses a Ru-catalyzed hydrogenation method for alpha,alpha-difluoroacetates, offering a scalable alternative to hydride reduction for pharmaceutical intermediates.
Advanced ruthenium catalyst technology for cyclic carbonate hydrogenation. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN110294689B details a green ruthenium-catalyzed method for converting primary amines to nitriles with high yield and hydrogen byproduct.
Patent CN112358379A reveals a high-efficiency asymmetric hydrogenation route for S-1,1-bis(4-fluorophenyl)propan-2-ol, offering superior purity and scalability for florypicoxamid production.